ReviewOncoTargets and therapy2018

Spotlight on copanlisib and its potential in the treatment of relapsed/refractory follicular lymphoma: evidence to date.

Felix A Mensah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.